-
Taxonomy & unit
-
ratio: %
-
Description
-
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
-
Summary
-
Royalty Pharma plc quarterly/annual Return On Equity history and growth rate from Q4 2020 to Q2 2025.
- Royalty Pharma plc Return On Equity for the quarter ending June 30, 2025 was 10.2 %, a 49.3% increase year-over-year.
- Royalty Pharma plc annual Return On Equity for 2024 was 8.54 %, a 26.1% decline from 2023.
- Royalty Pharma plc annual Return On Equity for 2023 was 11.6 %, a 2630% increase from 2022.
- Royalty Pharma plc annual Return On Equity for 2022 was 0.42 %, a 93% decline from 2021.
Return On Equity, Quarterly (%)
Return On Equity, YoY Quarterly Growth (%)